Altamira Therapeutics Announces Certification of Bentrio Nasal Spray under Medical Device Regulation November 20, 2025
Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of DNA Molecules November 3, 2025
Altamira Therapeutics Announces Allowance of Japanese Patent Application Covering Intranasal Betahistine July 15, 2025